Physician profile
John D Terrell
NPI 1528262318
$12,315.28
in general payments reported to CMS, 2019-2025
33 companies · $3,454 in 2025
The $3,454 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $875 · 2020: $168 · 2021: $1,177 · 2022: $1,263 · 2023: $1,584 · 2024: $3,795 · 2025: $3,454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,908 · Travel and Lodging: $2,144 · Consulting Fee: $720 · Education: $60.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,908.29 |
| Travel and Lodging | $2,143.58 |
| Consulting Fee | $720.04 |
| Education | $60.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $5,971.52 | 2019-2025 | Titan, Speedicath |
| Procept Biorobotics Corporation | $1,459.63 | 2021-2025 | Aquabeam Robotic System, Aquabeam System |
| Boston Scientific Corporation | $491.80 | 2019-2025 | Ams 700, Rezum Generator, Advance Xp |
| Astellas Pharma US INC | $478.87 | 2019-2024 | Xtandi |
| Janssen Biotech, INC. | $397.02 | 2019-2025 | Erleada, Akeega |
| Pfizer INC. | $348.51 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $346.73 | 2022-2025 | |
| Teleflex LLC | $300.16 | 2024-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $298.43 | 2023-2025 | Orgovyx, Gemtesa |
| Medtronic, INC. | $220.58 | 2021-2024 | Interstim |
| Axonics, INC. | $219.81 | 2021-2023 | Axonics |
| Rochester Medical Corporation | $217.82 | 2020-2022 | |
| Urogen Pharma, INC. | $216.35 | 2021-2024 | Jelmyto |
| Antares Pharma, INC. | $196.82 | 2019-2025 | Xyosted |
| Myovant Sciences INC. | $158.78 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $112.28 | 2021-2022 | |
| Abbvie INC. | $105.67 | 2023-2025 | Botox |
| Endo Pharmaceuticals INC. | $97.00 | 2021-2024 | Xiaflex, Aveed |
| Laborie Medical Technologies Corp. | $96.85 | 2023 | |
| Myriad Genetic Laboratories, INC. | $76.32 | 2024-2025 | Prolaris |
| Ambu INC. | $74.93 | 2025 | |
| Merck Sharp & Dohme LLC | $73.47 | 2021-2025 | Keytruda, Welireg |
| Ethicon US, LLC | $62.95 | 2019 | |
| Olympus America INC. | $61.80 | 2023-2025 | Itind System |
| Ferring Pharmaceuticals INC. | $49.51 | 2024-2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $42.63 | 2019 | |
| Endo USA, INC. | $33.67 | 2024-2025 | Xiaflex |
| Innovation Technologies INC | $22.81 | 2024 | Irrisept |
| Angiodynamics, INC. | $19.91 | 2025 | Nanoknife |
| Novo Nordisk INC | $17.56 | 2024 | Rivfloza |
| Allergan, INC. | $16.90 | 2022 | |
| Amgen INC. | $14.72 | 2021 | |
| Cook Medical LLC | $13.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Terrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.